Tick-borne lymphadenopathy (TIBOLA) acquired in Southwestern Germany
1 Center for Infectious Diseases and Travel Medicine, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany
2 Bundeswehr Institute of Microbiology, Neuherbergstrasse 11, 80937 Munich, Germany
BMC Infectious Diseases 2011, 11:167 doi:10.1186/1471-2334-11-167Published: 10 June 2011
Tick-borne lymphadenopathy (TIBOLA) was first described in 1997 in a patient in France. The causative agent, Rickettsia slovaca, is transmitted by Dermacentor ticks.
In southwestern Germany we encountered a patient with a tick bite at the dorsal scalp that resulted in an eschar and nuchal lymphadenopathy. Additionally, fever, malaise as well as elevated inflammatory markers and transaminases occurred. The characteristic clinical picture along with positive antibody testing for rickettsiae of the tick-borne spotted fever group strongly suggest the diagnosis TIBOLA.
Human rickettsioses are emerging infections. Clinicians should be aware of TIBOLA as a newly described rickettsial disease. As in our case, TIBOLA may be encountered in regions/countries where R. slovaca and Dermacentor ticks are prevalent but autochthonous acquisition was not described before.